Healthcare

https://techpapersworld.com/wp-content/uploads/2024/09/QingSong-Health-Chairman-Speaks-at-Global-1280x720.jpg

HealthcareQingSong Health Chairman Speaks at Global Ethics Forum in Geneva: Advancing Ethical Leadership in Healthcare

At the Global Ethics Forum, a leading platform that convenes stakeholders from various sectors to discuss peace, sustainability, and ethical leadership, the Chairman of QingSong Health, China’s premier healthcare solutions technology platform, delivered a compelling keynote address. The Forum serves as a multisectoral space for dialogue among institutions, policymakers, and experts, aimed at envisioning a future that emphasizes ethical engagement for better global outcomes. Founded in 2014, QingSong Health is dedicated to providing integrated healthcare solutions in China, serving...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/09/Aidoc-Launches-Seven-New-AI-1280x720.jpg

Artificial Intelligence HealthcareAidoc Launches Seven New AI Solutions to Tackle Europe’s Healthcare Challenges

Today, Aidoc, a leading healthcare AI provider, introduced seven new AI solutions to the European healthcare market. These additions mark a significant expansion of Aidoc’s award-winning aiOS™ platform, which alerts radiologists and care teams to suspected urgent pathologies in medical images, ensuring rapid delivery of treatment to patients. The new algorithms, which have now all achieved medical device CE-marking under MDR, include four solutions for notifying and triaging urgent pathologies: vessel occlusion, aortic dissection, vertebral compression fractures...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/Sonata-Software-Wins-Large-Multi-Year-1280x720.jpg

HealthcareSonata Software Wins Large Multi-Year, Multi-Million Dollar Strategic IT Outsourcing Deal From US-Based Premier Healthcare and Wellness Company

Sonata Software (NSE: SONATSOFTW) (BSE: 532221), a leading Modernization Engineering company, has announced that it has been chosen as a Strategic IT outsourcing partner by a US-based premier Healthcare and Wellness company. This strategic deal was successfully secured in June 2024, following an extensive evaluation and selection process and was also discussed during our Q1FY25 earnings call on July 31, 2024. The company’s primary focus is delivering personalized, high-quality care that addresses the unique needs of vulnerable patients...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/Be-Proactive-to-Prevent-Heart-Attacks-and-Strokes-1280x720.jpg

HealthcareBe Proactive to Prevent Heart Attacks and Strokes

(Family Features) Millions of Americans are at risk for life-threatening cardiovascular events due to high cholesterol, a condition nearly everyone has heard of yet just a fraction fully understand. In fact, many don’t realize they have high levels of harmful cholesterol until they experience a heart attack or stroke. According to the Centers for Disease Control and Prevention, 71 million adults in the United States have high low-density lipoprotein (LDL) cholesterol, also known as “bad” cholesterol. Of...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/LIAN-Group-Expands-Healthcare--1280x720.jpg

HealthcareLIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation

As part of its Healthcare investment platform, LIAN Group, an innovative owner- operator, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens and expands LIAN’s growing footprint in the healthcare industry, where it focuses on investing in the build-out of companies with leading solutions that address evolving needs. Scientis is a Swiss dermatology company dedicated to skin pigmentation with its flagship product Cyspera®. The Cyspera® product line, contains the proprietary Cysteamine Isobionic-Amide Complex™ , a clinically proven pigment corrector. Its unique formula features powerful antioxidant properties, and positions Cyspera as the first topical product to...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/myTomorrows-and-Pancreatic--1280x720.jpg

HealthcaremyTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials

myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with Pancreatic Cancer Europe, a multi-stakeholder platform that brings together experts from all over Europe with a common interest and willingness to improve care for patients with pancreatic cancer. Through the new partnership, Pancreatic Cancer Europe (PCE) will utilize myTomorrows’ vast database of ongoing clinical trials to equip patients, caregivers and healthcare professionals with up-to-date, accessible information about pre-approval treatments...

by PRNewswire

HealthcareLIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation

As part of their Healthcare investment platform, LIAN Group, an innovative investor and operator known for its healthcare investment in the #1 Swiss dentistry network, Cheeze, announces the acquisition of Scientis, a pioneering Swiss Cosmeceutical company. This acquisition strengthens LIAN’s healthcare footprint, as part of their cross-industry investments, focusing on leading solutions that address evolving needs. Scientis is a Swiss dermatology company dedicated to skin pigmentation with its flagship product Cyspera®. The Cyspera® product line,...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/SIFI-Receives-European-Commission--1280x720.jpg

HealthcareSIFI Receives European Commission Approval for AKANTIOR®

SIFI, a leading international ophthalmic company, today announced the European Commission has approved AKANTIOR® (polihexanide) for the treatment of acanthamoeba keratitis (AK) in adults and children from 12 years of age, confirming the orphan status of the product. AKANTIOR is the first and only approved therapy for people suffering from AK in Europe. AK is an ultra-rare, severe, progressive and sight threatening corneal infection characterized by intense pain and photophobia. AK is caused by a free-living...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/SOPHiA-DDM™-Platform-1280x720.jpg

HealthcareSOPHiA DDM™ Platform Certified Under IVDR

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA DDM™ Platform and allows customers throughout the European Union and other markets recognizing this certification to use the SOPHiA DDM™ Platform to support patient diagnostics. The...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/SPECTUM-DYNAMICS-MEDICAL-1280x720.jpg

HealthcareSPECTUM DYNAMICS MEDICAL AND DEEPDENSE MEDICAL ENTER INTO A PARTNERSHIP TO REVOLUTIONIZE AI IN CARDIAC AND SPINE DISEASE IMAGING AND TREATMENT

Spectrum Dynamics Medical, a leading innovator in digital SPECT-CT imaging solutions, announced that its partnering with DEEPDENSE Medical, developing innovative AI-based clinical applications to revolutionize Cardiac and Spine disease analysis. This collaboration aims to enhance the visualization and analysis of cardiac and spine diseases using advanced AI technology. By integrating DEEPDENSE’s AI algorithms with Spectrum Dynamics’ imaging systems, the partnership seeks to improve diagnostic accuracy, streamline workflows, and elevate patient care standards. Spectrum Dynamic’s customers...

Newer Posts

Older Posts